Lifevantage (NASDAQ:LFVN) Stock Passes Below 200-Day Moving Average - Time to Sell?

Key Points

• Lifevantage's stock price has dropped below its 200-day moving average, trading at $9.57 compared to the average of $12.88, raising questions about the stock's performance.
• Analysts have downgraded Lifevantage from a "strong-buy" to a "buy" rating, with a consensus price target of $30.50, despite recent underperformance in revenue.
• The company recently announced a quarterly dividend of $0.045 per share, yielding 1.9%, and insiders hold 21.95% of the stock, indicating potential insider confidence.

Lifevantage Corporation (NASDAQ:LFVN - Get Free Report)'s share price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $12.88 and traded as low as $9.47. Lifevantage shares last traded at $9.57, with a volume of 85,921 shares.

Analysts Set New Price Targets

Separately, Wall Street Zen cut Lifevantage from a "strong-buy" rating to a "buy" rating in a report on Saturday, September 6th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $30.50.

Lifevantage Stock Performance

The business has a 50-day simple moving average of $12.21 and a 200 day simple moving average of $12.88. The firm has a market cap of $121.44 million, a P/E ratio of 12.93 and a beta of 0.26.

Lifevantage (NASDAQ:LFVN - Get Free Report) last released its quarterly earnings results on Thursday, September 4th. The company reported $0.17 EPS for the quarter, meeting analysts' consensus estimates of $0.17. Lifevantage had a return on equity of 33.75% and a net margin of 4.29%.The business had revenue of $55.11 million during the quarter, compared to analyst estimates of $57.93 million. During the same quarter in the prior year, the company posted $0.14 EPS. Lifevantage has set its FY 2026 guidance at 1.000-1.15 EPS.

Lifevantage Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 16th. Shareholders of record on Monday, September 8th were issued a dividend of $0.045 per share. The ex-dividend date was Monday, September 8th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 1.9%. Lifevantage's dividend payout ratio is 24.32%.

Insider Buying and Selling at Lifevantage

In other Lifevantage news, Director Michael A. Beindorff sold 4,125 shares of the company's stock in a transaction that occurred on Tuesday, September 9th. The stock was sold at an average price of $11.44, for a total transaction of $47,190.00. Following the transaction, the director owned 22,858 shares in the company, valued at approximately $261,495.52. This represents a 15.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 21.95% of the company's stock.

Institutional Trading of Lifevantage

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Trexquant Investment LP purchased a new stake in Lifevantage during the 1st quarter valued at $1,607,000. Acadian Asset Management LLC boosted its stake in Lifevantage by 47.3% during the 1st quarter. Acadian Asset Management LLC now owns 291,700 shares of the company's stock valued at $4,248,000 after purchasing an additional 93,661 shares during the last quarter. Core Wealth Partners LLC purchased a new stake in Lifevantage during the 1st quarter valued at $480,000. Cambridge Investment Research Advisors Inc. boosted its stake in Lifevantage by 23.2% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 12,867 shares of the company's stock valued at $188,000 after purchasing an additional 2,421 shares during the last quarter. Finally, American Century Companies Inc. boosted its stake in Lifevantage by 28.1% during the 1st quarter. American Century Companies Inc. now owns 122,428 shares of the company's stock valued at $1,785,000 after purchasing an additional 26,876 shares during the last quarter. Hedge funds and other institutional investors own 35.32% of the company's stock.

Lifevantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.